
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 of a 4-Part Series
Hematologic Oncology Update
00:00
Is It OK to Use Bellantimab?
Bellantimab, Afodoten and Mel Flufan have been pulled off the market. Bellamaph can certainly be used because it is an ADC. So I'm not holding my breath for Melflufen, but Bellamaph, though, I do think there is a potential chance of it coming back.
Transcript
Play full episode